These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease. Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139 [TBL] [Abstract][Full Text] [Related]
4. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease. Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574 [TBL] [Abstract][Full Text] [Related]
5. Blood Neurofilament Light Chain in Parkinson's Disease: Comparability between Parkinson's Progression Markers Initiative (PPMI) and Asian Cohorts. Chen JH; Chan L; Chung CC; Bamodu OA; Hong CT J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768602 [TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma NFL and disease progression in Parkinson's disease: a prospective cohort study. Ou R; Liu K; Lin J; Yang T; Xiao Y; Wei Q; Hou Y; Li C; Zhang L; Jiang Z; Zhao B; Chen X; Song W; Wu Y; Shang H J Neurol; 2024 Apr; 271(4):1837-1843. PubMed ID: 38063869 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with Sheng ZH; Ma LZ; Liu JY; Ou YN; Zhao B; Ma YH; Tan L Front Aging Neurosci; 2022; 14():1061096. PubMed ID: 36589544 [TBL] [Abstract][Full Text] [Related]
8. Blood NfL: A biomarker for disease severity and progression in Parkinson disease. Lin CH; Li CH; Yang KC; Lin FJ; Wu CC; Chieh JJ; Chiu MJ Neurology; 2019 Sep; 93(11):e1104-e1111. PubMed ID: 31420461 [TBL] [Abstract][Full Text] [Related]
9. Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson's disease. Park DG; Kim JW; An YS; Chang J; Yoon JH J Neural Transm (Vienna); 2021 Dec; 128(12):1853-1861. PubMed ID: 34568970 [TBL] [Abstract][Full Text] [Related]
11. Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease. Chung CC; Chan L; Chen JH; Bamodu OA; Chiu HW; Hong CT FASEB J; 2021 Oct; 35(10):e21895. PubMed ID: 34478572 [TBL] [Abstract][Full Text] [Related]
12. Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease. Aamodt WW; Waligorska T; Shen J; Tropea TF; Siderowf A; Weintraub D; Grossman M; Irwin D; Wolk DA; Xie SX; Trojanowski JQ; Shaw LM; Chen-Plotkin AS Mov Disord; 2021 Dec; 36(12):2945-2950. PubMed ID: 34480363 [TBL] [Abstract][Full Text] [Related]
13. Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson's disease: An 8-year longitudinal study. Ye R; Locascio JJ; Goodheart AE; Quan M; Zhang B; Gomperts SN Parkinsonism Relat Disord; 2021 Apr; 85():11-16. PubMed ID: 33639572 [TBL] [Abstract][Full Text] [Related]
14. Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease. Lin CW; Lai TT; Chen SJ; Lin CH Geroscience; 2022 Jun; 44(3):1551-1562. PubMed ID: 35484471 [TBL] [Abstract][Full Text] [Related]
15. Cytokine profiles of plasma extracellular vesicles as progression biomarkers in Parkinson's disease. Chan L; Chung CC; Yu RC; Hong CT Aging (Albany NY); 2023 Mar; 15(5):1603-1614. PubMed ID: 36897204 [TBL] [Abstract][Full Text] [Related]
16. Plasma Total α-Synuclein and Neurofilament Light Chain: Clinical Validation for Discriminating Parkinson's Disease from Normal Control. Lin WC; Lu CH; Chiu PY; Yang SY Dement Geriatr Cogn Disord; 2020; 49(4):401-409. PubMed ID: 33242863 [TBL] [Abstract][Full Text] [Related]
17. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease. Chen CH; Lee BC; Lin CH J Parkinsons Dis; 2020; 10(1):77-88. PubMed ID: 31868681 [TBL] [Abstract][Full Text] [Related]
18. Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease. Zhu Y; Yang B; Wang F; Liu B; Li K; Yin K; Yin WF; Zhou C; Tian S; Ren H; Pang A; Yang X J Neuroimmunol; 2021 Sep; 358():577662. PubMed ID: 34311152 [TBL] [Abstract][Full Text] [Related]
19. Cytokine Profile in Plasma Extracellular Vesicles of Parkinson's Disease and the Association with Cognitive Function. Chan L; Chung CC; Chen JH; Yu RC; Hong CT Cells; 2021 Mar; 10(3):. PubMed ID: 33803292 [TBL] [Abstract][Full Text] [Related]
20. Plasma Exosomal Brain-Derived Neurotrophic Factor Correlated with the Postural Instability and Gait Disturbance-Related Motor Symptoms in Patients with Parkinson's Disease. Chung CC; Huang PH; Chan L; Chen JH; Chien LN; Hong CT Diagnostics (Basel); 2020 Sep; 10(9):. PubMed ID: 32932791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]